GDF1
Basic information
Region (hg38): 19:18868545-18896158
Links
Phenotypes
GenCC
Source:
- tetralogy of fallot (Limited), mode of inheritance: AD
- congenital heart defects, multiple types, 6 (Limited), mode of inheritance: AD
- conotruncal heart malformations (Limited), mode of inheritance: AD
- congenital heart defects, multiple types, 6 (Limited), mode of inheritance: AD
- right atrial isomerism (Limited), mode of inheritance: AR
- right atrial isomerism (Supportive), mode of inheritance: AR
- congenital heart defects, multiple types, 6 (No Known Disease Relationship), mode of inheritance: AD
- congenital heart defects, multiple types, 6 (Definitive), mode of inheritance: AR
- conotruncal heart malformations (Limited), mode of inheritance: Unknown
- right atrial isomerism (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital heart defects, multiple types, 6; Right atrial isomerism | AD/AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Gastrointestinal; Pulmonary | 17924340; 20413652; 28991257 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (7 variants)
- Progressive myoclonic epilepsy type 8 (1 variants)
- Visceral heterotaxy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GDF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 38 | 42 | ||||
missense | 71 | 79 | ||||
nonsense | 7 | |||||
start loss | 0 | |||||
frameshift | 15 | |||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 10 | 17 | 2 | 29 | ||
non coding | 130 | 121 | 259 | |||
Total | 9 | 16 | 213 | 161 | 10 |
Highest pathogenic variant AF is 0.0000272
Variants in GDF1
This is a list of pathogenic ClinVar variants found in the GDF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-18868612-C-T | Likely benign (Sep 06, 2019) | |||
19-18868614-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
19-18868620-C-A | not specified | Uncertain significance (Dec 08, 2021) | ||
19-18868621-C-T | Likely benign (Aug 27, 2022) | |||
19-18868623-CCAT-C | Right atrial isomerism | Pathogenic (Apr 18, 2018) | ||
19-18868624-C-T | Likely pathogenic (Apr 02, 2021) | |||
19-18868625-A-G | Congenital heart defects, multiple types, 6 • Heart, malformation of | Pathogenic/Likely pathogenic (Sep 08, 2023) | ||
19-18868629-C-G | GDF1-related disorder | Uncertain significance (Jun 21, 2024) | ||
19-18868640-C-T | Uncertain significance (May 27, 2022) | |||
19-18868641-G-A | Uncertain significance (Oct 13, 2022) | |||
19-18868650-C-T | Uncertain significance (Jan 05, 2024) | |||
19-18868664-T-TCAAAGAAGAGCA | Uncertain significance (May 11, 2020) | |||
19-18868665-CAAAG-C | Congenital heart defects, multiple types, 6 | Pathogenic/Likely pathogenic (Jan 25, 2023) | ||
19-18868666-AAAG-A | Visceral heterotaxy • Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 31, 2021) | ||
19-18868673-A-G | Uncertain significance (Jul 28, 2023) | |||
19-18868675-C-A | GDF1-related disorder | Likely benign (May 29, 2022) | ||
19-18868678-G-A | Likely benign (Apr 02, 2018) | |||
19-18868681-G-A | Likely benign (Feb 23, 2023) | |||
19-18868686-G-A | Uncertain significance (Sep 01, 2021) | |||
19-18868687-C-T | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 10, 2018) | ||
19-18868688-G-C | Uncertain significance (Aug 08, 2019) | |||
19-18868697-G-C | Uncertain significance (Dec 03, 2020) | |||
19-18868700-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
19-18868700-G-T | Uncertain significance (Dec 05, 2020) | |||
19-18868708-G-C | - | no classification for the single variant (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GDF1 | protein_coding | protein_coding | ENST00000247005 | 2 | 27545 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.412 | 0.555 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.69 | 102 | 163 | 0.626 | 0.0000121 | 2207 |
Missense in Polyphen | 39 | 69.186 | 0.5637 | 836 | ||
Synonymous | 1.95 | 59 | 81.4 | 0.725 | 0.00000681 | 889 |
Loss of Function | 1.70 | 1 | 5.17 | 0.194 | 2.61e-7 | 72 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May mediate cell differentiation events during embryonic development.;
- Disease
- DISEASE: Congenital heart defects, multiple types, 6 (CHTD6) [MIM:613854]: An autosomal dominant disorder characterized by congenital developmental abnormalities involving structures of the heart. Common defects include tetralogy of Fallot, transposition of the great arteries, double-outlet right ventricle, total anomalous pulmonary venous return, pulmonary stenosis or atresia, atrioventricular canal, ventricular septal defect, and hypoplastic left or right ventricle. {ECO:0000269|PubMed:17924340, ECO:0000269|PubMed:28991257}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. {ECO:0000269|PubMed:17924340}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Right atrial isomerism (RAI) [MIM:208530]: A severe complex congenital heart defect resulting from embryonic disruption of proper left-right axis determination. RAI is usually characterized by complete atrioventricular septal defect with a common atrium and univentricular AV connection, total anomalous pulmonary drainage, and transposition or malposition of the great arteries. Affected individuals present at birth with severe cardiac failure. Other associated abnormalities include bilateral trilobed lungs, midline liver, and asplenia, as well as situs inversus affecting other organs. {ECO:0000269|PubMed:20413652, ECO:0000269|PubMed:28991257}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- TGF-Core;Metabolism of lipids;Metabolism;ceramide <i>de novo</i> biosynthesis;Sphingolipid de novo biosynthesis;Sphingolipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.121
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- N
- hipred_score
- 0.285
- ghis
- 0.396
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gdf1
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; respiratory system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- regulation of signaling receptor activity;positive regulation of pathway-restricted SMAD protein phosphorylation;BMP signaling pathway;regulation of apoptotic process;regulation of MAPK cascade;cell development;SMAD protein signal transduction
- Cellular component
- extracellular space
- Molecular function
- cytokine activity;transforming growth factor beta receptor binding;growth factor activity